Skip to main content

Advertisement

SpringerLink
Log in

Overactive bladder and men: Indications for anticholinergics

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Similar to bladder outlet obstruction (BOO), overactive bladder (OAB) symptoms are very common and increase in prevalence as men age. Whether or not OAB symptoms are thought to be secondary to BOO, the goal of treatment of symptoms should result in an improved quality of life and ultimately prevent clinical deterioration. A common dilemma when treating men with obstruction and OAB is the risk of acute urinary retention or morbidities related to increasing postvoid residuals. In this article, the relationship of OAB to BOO is examined and the role of urodynamics and data on the use of anticholinergics in men with OAB and obstruction are reviewed. An algorithm for managing men with OAB also is proposed. In men with OAB without evidence of obstruction (including OAB after treatment for BOO), first-line medical therapy with anticholinergics is indicated. However, in men with OAB and concomitant BOO, nomogram has been developed to assist in the management of patients at risk for urinary retention. Men with significant obstruction should be appropriately treated to decrease bladder outlet resistance before adding anticholinergics for the treatment of OAB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Abrams P, Cardozo L, Fall M, et al.: The standardization of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002, 21:167–178. This useful report from the ICS standardizes the definitions and terminology for urodynamic studies, LUTS, and dysfunction for patients of all ages and gender.

    Article  PubMed  Google Scholar 

  2. Milsom I, Abrams P, Cadrozo L, et al.: How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001, 87:760–766. This is a population-based survey of more than 16,000 men and women older than 40 years of age designed to estimate the prevalence of OAB symptoms. Approximately 16% of the patients complained of OAB symptoms, with only minor differences between men and women. Advancing age corresponded to the increased likelihood of reporting symptoms.

    Article  PubMed  CAS  Google Scholar 

  3. Stewart W, Herzog AR, Wein A, et al.: Prevalence and impact of overactive bladder in the US: results from the NOBLE program. Neurourol Urodyn 2001, 20:406.

    Google Scholar 

  4. Dmochowski R, Staskin D: OAB in men: special considerations for evaluation and management. Urology 2002, 60(suppl 1):56–62.

    Article  PubMed  Google Scholar 

  5. Welch G, Weinger K, Barry MJ: Quality-of-life impact of lower urinary tract symptom severity: results form the Health Professionals Follow-up Study. Urology 2002, 59:245–250.

    Article  PubMed  Google Scholar 

  6. Kaplan SA, Bowers DL, Te AE, et al.: Differential diagnosis of prostatism: a 12-year retrospective analysis of symptoms, urodynamics, and satisfaction with therapy. J Urol 1996, 155:1305–1308. This is a retrospective analysis of 2845 consecutive men with LUTS who underwent urodynamic evaluation in a 12-year period. Of these patients, 523 (62%) had verifiable evidence of BOO of whom 345 (66%) had concomitant DO. Of the entire group, 843 (77%) had evidence of DO, which was the sole diagnosis in 199 (24%). Surgical treatment was associated with a higher level of satisfaction than was medical therapy, regardless of the urodynamic presence of BOO.

    Article  PubMed  CAS  Google Scholar 

  7. Eckhardt MD, van Venrooij GE, Boon TA: Interactions between prostate volume, filling cystometric estimated parameters, and data from pressure-flow studies in 565 men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Neurourol Urodyn 2001, 20:579–590. A group of 565 men with LUTS suggestive of BPH were assessed with urodynamics; only 53% were confirmed to have obstruction and 46% had DO. Increased grades of obstruction were associated with increasing likelihood of DO. Although this study did not find a correlation between age and BOO, patients with DO were older than those without.

    Article  PubMed  CAS  Google Scholar 

  8. Eckhardt MD, van Venrooij GE, Boon TA: Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology 2001, 57:695–700. This study is from the same investigators and patient population described in the previous reference. Symptoms on the IPSS were not found to correlate with objective measurements on urodynamic evaluation. Of the 259 (46%) men with DO, scores of frequency, urgency, and nocturia were significantly higher compared with men with a stable bladder. However, the difference in symptom index was not significant.

    Article  PubMed  CAS  Google Scholar 

  9. Hyman MJ, Groutz A, Blaivas JG: Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J Urol 2001, 166:550–553. This is a study of 160 consecutive neurologically intact men with LUTS who underwent urodynamic evaluation. Of the 68% of men with demonstrable BOO, 46% had concomitant DO. Evidence for DO was identified in 75% of men with a chief complaint of urge incontinence. Other than the expected correlation of urge incontinence with DO, no other symptom was found to correlate well with any specific urodynamic finding.

    Article  PubMed  CAS  Google Scholar 

  10. Knutson T, Edlund C, Fall M, et al.: BPH with coexisting overactive bladder dysfunction: an everyday urological dilemma. Neurourol Urodyn 2001, 20:237–247. One hundred and sixty-two consecutive men underwent urodynamic evaluation for LUTS; 55% had BOO alone and 45% had concomitant BOO and DO. Men with DO were more likely to be older, have BOO, and have higher prostate-specific antigen levels. Symptom scores, maximum flow rate, and PVR did not differ between groups.

    Article  PubMed  CAS  Google Scholar 

  11. Atan A, Horn T, Hansen F, et al.: Benign prostatic hyperplasia: Does a correlation exist between prostatic morphology and irritative symptoms? Scand J Urol Nephrol 1996, 30:303–306.

    PubMed  CAS  Google Scholar 

  12. Abdel-Aziz KF, Lemack G: Overactive bladder in the male patient: bladder, outlet, or both? Curr Urol Rep 2002, 3:445–451.

    Article  PubMed  Google Scholar 

  13. Dupont MC, Persson K, Spitskergent D, et al.: The neuronal response to bladder outlet obstruction: a role for NGF. Adv Exp Med Biol 1995, 385:41–54.

    PubMed  CAS  Google Scholar 

  14. Gosling JA, Gilpin SA, Dixon JS: Decrease in the autonomic innervation of human detrusor muscle in outflow obstruction. J Urol 1986, 136:501–504.

    PubMed  CAS  Google Scholar 

  15. Speakman MJ, Brading AF, Gilpin CJ, et al.: Bladder outflow obstruction: a cause of denervation supersensitivity. J Urol 1987, 138:1461–1466.

    PubMed  CAS  Google Scholar 

  16. Elbadawi A, Yalla SV, Resnick NM: Structural basis of geriatric voiding dysfunction. IV: bladder outlet obstruction. J Urol 1993, 150:1681–1695.

    PubMed  CAS  Google Scholar 

  17. Elbadawi A, Meyer S: Morphometry of the obstructed detrusor, I: review of the issues. Neurourol Urodyn 1989, 8:163–172.

    Article  Google Scholar 

  18. Holn NR, Horn T, Hald T: Bladder wall morphology in aging and obstruction. Scand J Urol Nephrol 1995, 29:45–49.

    Article  Google Scholar 

  19. Madersbacher S, Pycha A, Klingler CH, et al.: Interrelationships of bladder compliance with age, detrusor instability, and obstruction in elderly men with lower urinary tract symptoms. Neurourol Urodyn 1999, 18:3–15. A group of 170 men older than 50 years of age with LUTS were observed with urodynamics to determine which clinical and urodynamic parameters influence bladder compliance (BC) in elderly men. They found that BC decreases with advanced age, BOO, higher voiding pressures, and DO in men with LUTS. A multivariate analysis identified DO, bladder capacity, and maximum detrusor pressure as independent predictors for a low BC.

    Article  PubMed  CAS  Google Scholar 

  20. Wadie BS, Ebrahim EE, Gomha MA: The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study. J Urol 2002, 168:132–134.

    Article  PubMed  Google Scholar 

  21. Kaplan SA, Te AE, Blaivas JG: Urodynamic parameters in patients with diabetic cystopathy. J Urol 1995, 153:342–344. This is a review of 182 consecutive patients with diabetes who underwent videourodynamic evaluation. They found that 55% had DO, 23% had impaired detrusor contractility, 11% had indeterminate findings, 10% had detrusor areflexia, and 1% had no abnormalities. BOO occurred in 57% of the men. These data suggest that the “classical” diabetic cystopathy is not the most common urodynamic finding in patients with diabetes and voiding dysfunction; in fact, these patients may present with variable pathophysiologic findings.

    Article  PubMed  CAS  Google Scholar 

  22. Nitti V, Ficazzola M: Bladder neck dysfunction in young males [Abstract]. J Urol 1999, 161:256A.

    Article  Google Scholar 

  23. Kaplan SA, Te AE, Jacobs BZ: Urodynamic evidence of vesical neck obstruction win men misdiagnosed with chronic nonbacterial prostatitis and the therapeutic role of endoscopic incision of the bladder neck. J Urol 1994, 152:2063–2065.

    PubMed  CAS  Google Scholar 

  24. Kaplan SA, Santarosa RP, D’Alisera et al.: Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option. J Urol 1997, 157:2234–2237.

    Article  PubMed  CAS  Google Scholar 

  25. Kaplan SA, Ikeguchi EF, Santarosa RP, et al.: Etiology of voiding dysfunction in men less than 50 years of age. Urology 1996, 47:836–839.

    Article  PubMed  CAS  Google Scholar 

  26. Machino R, Kakizaki H, Ameda K, et al.: Detrusor instability with equivocal obstruction: a predictor of unfavorable symptomatic outcomes after transurethral prostatectomy. Neurourol Urodyn 2002, 21:444–449.

    Article  PubMed  Google Scholar 

  27. Van Venrooij GE, Van Melick HHE, Eckhardt MD, et al.: Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate. J Urol 2002, 169:605–609. This is a study of 93 men who underwent urodynamic evaluation before and 6 months after a TURP. Of the men who had evidence of DO preoperatively, 50% had no evidence of DO after TURP. Of those with a stable bladder preoperatively, 90% remained stable after TURP.

    Article  Google Scholar 

  28. Nitti VW, Kim Y, Combs AJ: Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings. J Urol 1997, 157:600–603. This is a study of 50 consecutive men with voiding dysfunction after TURP who were evaluated urodynamically. More than 50% of these patients had demonstrable DO. In the 20 patients with post-TURP incontinence, 75% were found to have DO. Only 16% of patients with postoperative voiding dysfunction were found to be obstructed.

    Article  PubMed  CAS  Google Scholar 

  29. Herbison P, Hay-Smith J, Ellis G, et al.: Effectiveness of anticholinergics drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 2003, 326:841–844.

    Article  PubMed  CAS  Google Scholar 

  30. Abrams P, Kaplan S, Millard R: Tolterodine treatment is safe in men with bladder outlet obstruction and symptomatic detrusor overactivity. Proceedings of the International Continence Society 32nd Annual Meeting. Seoul, Korea: September 18–20, 2001:107.

  31. Athanasopoulos A, Gyfopoulos K, Giannitsas et al.: Combination treatment with an _-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study. J Urol 2003, 169:2253–2256. A study of 50 consecutive patients with urodynamically proven BOO and concomitant DO who were randomized to treatment with either tamsulosin (_-blocker) alone or tamsulosin and tolterodine (antimuscarinic). Combination treatment safely improved symptomatic quality of life without significant increases in PVR and without any episodes of urinary retention during the 3 months of the study.

    Article  PubMed  CAS  Google Scholar 

  32. Dmochowski RR, Staskin DR: Advances in drug delivery: improved bioavailability and drug effect. Curr Urol Rep 2002, 3:439–444.

    Article  PubMed  Google Scholar 

  33. Rossi C, Kortmann BB, Sonke GS, et al.: Alpha-blockade improves symptoms suggestive of bladder obstruction, but fails to relieve it. J Urol 2001, 165:38–41.

    Article  PubMed  CAS  Google Scholar 

  34. Arnold EP: Tamsulosin in men with confirmed bladder obstruction: a clinical and urodynamic analysis from a single center in New Zealand. BJU Int 2001, 87:24–30.

    Article  PubMed  CAS  Google Scholar 

  35. Te A, Ghafar MA, Ostad E, et al.: Nomogram and urodynamic predictors of urinary retention in men with BPH and bladder outlet obstruction [Abstract]. Presented at the American Urological Association Annual Meeting. Anaheim, CA: June 2–7, 2001; 1996.

Download references

Author information

Authors and Affiliations

  1. Brady Prostate Center, Department of Urology, New York Presbyterian Hospital, Weill Medical College of Cornell University, 525 East 68th Street, Suite F918, 10021, New York, NY, USA

    Alexis E. Te MD

Authors
  1. Ricardo R. González MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexis E. Te MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

González, R.R., Te, A.E. Overactive bladder and men: Indications for anticholinergics. Curr Urol Rep 4, 429–435 (2003). https://doi.org/10.1007/s11934-003-0022-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-003-0022-2

Keywords

Search

Navigation